Deeptech factory
Unlocking the full potential of cancer treatment and care with artificial intelligence
TheraPanacea is a software solutions editor using AI to transform cancer care through prognosis and treatment solutions.
CEO: Nikolaos Paragios
Creation: march 2017
Headcount: 75
TECHNO / PRODUCTS
TheraPanacea vision is to introduce the first, self-contained, self-trained paradigm to thrive cancer research and treatment in a new dimension targeting drug development, treatment selection, treatment assessment and optimization of clinical outcomes.
TheraPanacea offers a new/fully holistic approach for cancer research & treatment referring to macro/micro/nano scale integration of medicine, information theory and computational medicine.
PRODUCTS PORTFOLIO
APPLICATIONS
TheraPanacea is a highly ambitious artificial intelligence-powered French spinoff medical technology company exploiting state-of-the-art research technology with origins from Ecole CentraleSupelec, Inria and Gustave Roussy Institute.
TheraPanacea brings to the radiation therapy market the latest inter-disciplinary technological advances from the associated research laboratories (machine learning, AI, advanced mathematics).
BENEFITS
TheraPanacea benefits:
– 100% web solution (technologie Cloud)
– Ready-to-use plug and play at hospitals
– Up to 90% of expert time gained in fastidious hence critical operations
– L18Smart automation (deep-learning one-click solutions)
THERAPANACEA MINUTE
